Align Technology, Inc. vs ARK Space & Defense Innovation ETF — how do they compare? Align Technology, Inc. trades at $173.38 (market cap $12.29B), while ARK Space & Defense Innovation ETF trades at $34.73. Which is the better fit depends on your goals.
| ALGN | ARKX | |
|---|---|---|
Market Cap | $12.29B | — |
Sector | Health | Sector/Thematic |
52-Week High | $197.51 | $37.74 |
52-Week Low | $124.88 | $25.46 |
Enterprise Value | $11.30B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $174.63, down 0.8% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with record revenue and clear aligner volume. Fundamentals show solid profitability with a 68.05% gross margin and 9.99% net income margin, though revenue growth has moderated. Recent news highlights a patent win in China and strategic initiatives following activist investor engagement.
The outlook is mixed: analyst consensus is strongly bullish (73% buy ratings), but technicals and slowing revenue growth pose near-term risks. Investment opportunity lies in international expansion and digital dentistry platform growth, while risks include competitive pressures and execution of new strategic initiatives. The stock's valuation at 30x P/E requires sustained earnings growth to justify.
ARKX trades at $34.69, up 0.81% with a bullish technical signal from moving averages and ADX indicators. The ETF focuses on space and defense innovation, with key holdings like SpaceX and Rocket Lab. Recent news highlights strong interest in space economy ETFs as alternatives to direct SpaceX investment, with ARKX noted for outperforming peers in one-year returns despite higher volatility.
The outlook for ARKX is positive due to growing space industry tailwinds, but risks include high expense ratios and volatility. Investment appeal lies in diversified exposure to disruptive tech, though valuation concerns for holdings like SpaceX and competitive ETF options warrant caution for risk-averse investors.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.
Read more on ARKX →